FDA Takes Caution on Approving New Drugs
August 18, 2007 By LINDA A. JOHNSON, AP Business Writer
Graphic shows Food and Drug Administration drug approvals through July
(AP) -- Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
Similar stories from PHYSorg:
FDA finds bits of steel, rubber in Genzyme drugs
Nov 13, 2009 |
5 / 5 (2) |
0
US adult smoking rate rises slightly
Nov 12, 2009 |
not rated yet |
1
HP's 3Com takeover marks a shot at Cisco
Nov 11, 2009 |
not rated yet |
0
Review: Reports on Pfizer drug studies misleading
Nov 11, 2009 |
3.8 / 5 (4) |
5
Drug industry presses FDA to allow more online ads
Nov 11, 2009 |
not rated yet |
1
